6月25日，安捷伦科技盘中上涨5.12%，报138.37美元/股，成交额5991.62万美元。
消息面上，安捷伦科技宣布已完成对Biocare Medical的收购，交易对手方为Excellere Partners和GHO Capital Partners领导的投资者集团。Biocare Medical将正式并入安捷伦生命科学与诊断市场集团，此次收购被视为公司在病理学产品组合上的战略扩张，标志着其在数字化病理学平台及高精度癌症染色诊断领域迈出关键一步。
此外，近期多重利好叠加支撑股价：巴克莱将目标价从145美元上调至150美元并维持跑赢大盘评级；公司此前第二财季调整后EPS为1.49美元，超市场预期的1.41美元，营收18.4亿美元亦超预期，同时上调全年指引至EPS 6.00-6.10美元。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.